Results 111 to 120 of about 5,054 (133)

Outcome and Safety of Different Cumulative Doses and Protocols of Intravenous Methylprednisolone in Moderate to Severe and Active Graves’ Ophthalmopathy

Ophthalmologica Indonesiana, 2019
Background: Graves’ ophthalmopathy (GO), also known as Graves’ orbitopathy or thyroid eye disease, has a potential sight-threatening complications. The activity and severity are important determinants in GO and are implications for treatment. Intravenous Glucocorticoid (GC) was associated with significantly greater efficacy and
Amelya Permata Sari   +2 more
openaire   +1 more source

Association between Graves' ophthalmopathy and smoking

Lancet, The, 1990
O M Edwards, A P Weetman
exaly  

Cytokines in the Evolution of Graves' Ophthalmopathy

Autoimmunity, 1997
Neena Natt, R S Bahn, N Natt
exaly  

MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease

Lancet, The, 2001
A Allahabadia, J M Heward, J A Franklyn
exaly  

Ophthalmopathy and hyperthyroidism

Acta Ophthalmologica, 1986
M Soderstrom
exaly  

Home - About - Disclaimer - Privacy